Life Technologies CEO Defends Price for Ion Torrent, Dismisses Illumina's PCR System | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Disputing the notion that it paid too high of a price for Ion Torrent, Life Technologies CEO Greg Lucier defended the acquisition — which could cost as much as $725 million — saying that Ion Torrent's technology will "revolutionize the whole genetic testing market."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.